Spero Therapeutics, Inc. Human Resources Contracts & Agreements
46 Contracts & Agreements
- Bonus & Incentive Agreements (16 contracts)
- Compensation Agreements (4)
- Consulting Agreements (10)
- Employment Agreements (11)
- Separation Agreements (5)
- Consulting Agreement, effective as of August 5, 2024, by and between the Registrant and John C. Pottage, Jr., M.D (Filed With SEC on November 14, 2024)
- Separation Agreement, dated July 30, 2024, by and between the Registrant and Kama Hamed (Filed With SEC on November 14, 2024)
- Consulting Agreement, effective as of August 29, 2024, by and between the Registrant and Kamal Hamed (Filed With SEC on November 14, 2024)
- Consulting Agreement, dated February 9, 2024, by and between the Registrant and Tamara Joseph (Filed With SEC on March 13, 2024)
- Separation Agreement, dated February 9, 2024, by and between the Registrant and Tamara Joseph (Filed With SEC on March 13, 2024)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 13, 2024)
- 2019 Inducement Equity Incentive Plan, as amended (Filed With SEC on March 13, 2024)
- Spero Therapeutics, Inc. 2017 Stock Incentive Plan, as amended (Filed With SEC on October 10, 2023)
- Consulting Agreement, dated June 12, 2023, by and between the Registrant and Danforth Advisors, LLC (Filed With SEC on August 10, 2023)
- Amended and Restated Employment Agreement, dated June 13, 2023, by and between the Registrant and Satyavrat Shukla (Filed With SEC on August 10, 2023)
- Consulting Agreement, dated June 13, 2023, by and between the Registrant and Ankit Mahadevia, M.D (Filed With SEC on August 10, 2023)
- Transition and Separation Agreement, dated June 13, 2023, by and between the Registrant and Ankit Mahadevia, M.D (Filed With SEC on August 10, 2023)
- Second Amendment to Employment Agreement, dated as of February 1, 2023, by and between the Registrant and Timothy Keutzer (Filed With SEC on May 11, 2023)
- Amendment 1 to Consulting Agreement, dated August 4, 2022, by and between the Registrant and Cristina Larkin (Filed With SEC on November 14, 2022)
- Spero Therapeutics, Inc. 2017 Stock Incentive Plan, as amended (Filed With SEC on September 19, 2022)
- Consulting Agreement, dated May 3, 2022, by and between the Registrant and David Melnick, M.D (Filed With SEC on August 10, 2022)
- Consulting Agreement, dated May 3, 2022, by and between the Registrant and Cristina Larkin (Filed With SEC on August 10, 2022)
- Separation Agreement, dated May 3, 2022, by and between the Registrant and David Melnick, M.D (Filed With SEC on August 10, 2022)
- Separation Agreement, dated May 3, 2022, by and between the Registrant and Cristina Larkin (Filed With SEC on August 10, 2022)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 31, 2022)
- Form of Restricted Stock Unit Agreement under the 2017 Stock Incentive Plan, as amended (Filed With SEC on August 30, 2021)
- Spero Therapeutics, Inc. 2017 Stock Incentive Plan, as amended (Filed With SEC on August 18, 2021)
- Employment Agreement, dated November 6, 2020, by and between the Registrant and Tamara Joseph (Filed With SEC on March 11, 2021)
- Employment Agreement, dated December 9, 2020, by and between the Registrant and Satyavrat Shukla (Filed With SEC on March 11, 2021)
- Amended and Restated Employment Agreement, dated April 22, 2020, by and between the Registrant and Thomas Parr Jr., Ph.D (Filed With SEC on August 6, 2020)
- Form of Stock Option Agreement under the 2019 Inducement Equity Incentive Plan, as amended (Filed With SEC on August 6, 2020)
- 2019 Inducement Equity Incentive Plan, as amended (Filed With SEC on August 6, 2020)
- Consulting Agreement, dated November 4, 2019, by and between the Registrant and Danforth Advisors, LLC (Filed With SEC on May 8, 2020)
- Consulting Agreement, dated April 18, 2019, by and between the Registrant and David P. Southwell (Filed With SEC on March 16, 2020)
- Employment Agreement, dated January 1, 2020, by and between the Registrant and Timothy Keutzer (Filed With SEC on March 16, 2020)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 16, 2020)
- Form of Stock Option Agreement under the 2019 Inducement Equity Incentive Plan (Filed With SEC on March 14, 2019)
- 2019 Inducement Equity Incentive Plan (Filed With SEC on March 14, 2019)
- Employment Agreement, dated December 13, 2017, by and between the Registrant and David Melnick, M.D (Filed With SEC on April 2, 2018)
- Form of Stock Option Agreement under the Spero Therapeutics, Inc. 2017 Stock Incentive Plan, as amended (Filed With SEC on December 14, 2017)
- Spero Therapeutics, Inc. 2017 Stock Incentive Plan, as amended (Filed With SEC on December 14, 2017)
- Non-Employee Director Compensation Policy (Filed With SEC on October 23, 2017)
- Form of Stock Option Agreement under 2017 Stock Incentive Plan, as amended (to become effective upon completion of this offering) (Filed With SEC on October 23, 2017)
- 2017 Stock Incentive Plan, as amended (to become effective upon completion of this offering) (Filed With SEC on October 23, 2017)
- Employment Agreement, dated October 20, 2017, by and between the Registrant and Cristina Larkin (Filed With SEC on October 23, 2017)
